Intracellular pathogens and danger signals trigger the formation of inflammasomes, which activate inflammatory caspases and induce pyroptotic cell death. The anthrax lethal factor metalloprotease and small molecule DPP8/9 inhibitors both activate the Nlrp1b inflammasome, but the molecular mechanism of Nlrp1b activation is not known. Here, we used genome-wide 5 CRISPR/Cas9 knockout screens to identify genes required for Nlrp1b-mediated pyroptosis, and discovered that lethal factor induces cell death via the N-end rule proteasomal degradation pathway. Lethal factor directly cleaves Nlrp1b, which induces the N-end rule-mediated degradation of the Nlrp1b N-terminus and thereby frees the Nlrp1b C-terminus to activate caspase-1. DPP8/9 inhibitors also induce proteasomal degradation of the Nlrp1b N-terminus, but, in 10 contrast, not through the N-end rule pathway. Overall, these data reveal that N-terminal degradation is the common mechanism for activation of this innate immune sensor protein. 15 One Sentence Summary: Proteasome-mediated degradation of the Nlrp1b N-terminus releases the Nlrp1b C-terminus to activate caspase-1 and induce pyroptotic cell death. 20 3 Main Text: Mammals express a diverse array of intracellular pattern-recognition receptors (PRRs) that detect cytoplasmic microbial structures and activities, including bacterial flagellin, double stranded DNA, and pathogen modification of host Rho GTPases (1, 2). Upon recognition of their cognate danger signals, several PRRs form large, multiprotein complexes called inflammasomes, which recruit and activate the inflammatory protease caspase-1. Active caspase-5 1, in turn, cleaves and activates inflammatory cytokines and Gsdmd, which mediates a form of lytic cell death called pyroptosis and stimulates a powerful immune response (1, 3, 4) .
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Main Text: Mammals express a diverse array of intracellular pattern-recognition receptors (PRRs) that detect cytoplasmic microbial structures and activities, including bacterial flagellin, double stranded DNA, and pathogen modification of host Rho GTPases (1, 2) . Upon recognition of their cognate danger signals, several PRRs form large, multiprotein complexes called inflammasomes, which recruit and activate the inflammatory protease caspase-1. Active caspase- 5 1, in turn, cleaves and activates inflammatory cytokines and Gsdmd, which mediates a form of lytic cell death called pyroptosis and stimulates a powerful immune response (1, 3, 4) .
Mouse Nlrp1b is a member of the nucleotide-binding domain and leucine rich repeat containing (NLR) family of intracellular PRRs that can form an inflammasome (1, 2, 5) . Anthrax lethal toxin (LT) is the best-characterized activator of the Nlrp1b inflammasome (5, 6) . LT is a 10 bipartite toxin consisting of lethal factor (LF), a zinc metalloprotease, and protective antigen (PA), a cell binding-protein that transports LF into the host cell cytosol. LF directly cleaves Nlrp1b after lysine 44, and this cleavage is required for inflammasome formation (7) (8) (9) . However, it remains unknown how proteolytic cleavage results in the activation of Nlrp1b. We recently discovered that small molecule inhibitors of the host serine dipeptidases DPP8 and DPP9 (DPP8/9) also 15 activate Nlrp1b (10) (11) (12) . It is not known how DPP8/9 inhibition stimulates formation of the Nlrp1b inflammasome, but, unlike LT-induced activation, it does not involve the direct cleavage of Nlrp1b (11). Intriguingly, proteasome inhibitors block both LT-and DPP8/9 inhibitor-induced pyroptosis (11, 13, 14) , but do not block pyroptosis mediated by other inflammasomes (14, 15) . Thus, although LT and DPP8/9 inhibitors activate Nlrp1b in different ways, a key component of the 20 Nlrp1b activation mechanism -the degradation of some key protein -appears to be shared between these two stimuli.
Here, we wanted to further investigate the mechanism of Nlrp1b activation. We first performed two genome-wide CRISPR/Cas9 screens in the mouse RAW 264.7 macrophage cell line, which is sensitive to both DPP8/9 inhibitors and anthrax LT (10, 11, 13) , to identify gene knockouts that provide resistance to the DPP8/9 inhibitor Val-boroPro (VbP) and/or LT (Fig.   S1A ). The top two most enriched sgRNAs for each gene were used to rank each overall gene's 5 enrichment by RIGER analysis (Fig. 1A, Fig. S1B ,C) (16, 17) . As expected, Nlrp1b, Casp1, and Gsdmd were among the most enriched genes after both LT and VbP selection. In fact, these were the three highest scoring genes in the VbP screen. Nlrp1a, which is not expressed in Balb/c macrophages from which RAW 264.7 cells were derived (18), was also enriched, but this is likely due to off-target knockout of Nlrp1b by the Nlrp1a sgRNAs. Also as expected, many genes that 10 encode proteins known to be required for LT cell penetrance, including the anthrax toxin receptor Antxr2 (19), the cell surface protease furin (20, 21), and members of the vacuolar ATPase proton pump (22), were highly enriched in LT-treated samples (Fig. 1A ).
In addition to these expected results, several genes with no known association with inflammasome biology were also identified. For example, genes encoding members of the protein 15 folding and chaperoning machinery (Dnaja2, Stip1, and Hsp90ab1) (23-25), the Mettl3-Mettl14 complex that mediates N 6 -adenosine methylation (Mettl3, Mettl14, Wtap, Zc3h13, and Virma) (26-28), and the Ino80 chromatin remodeling complex (Ino80, Ino80b, Ino80c, Actr5, and Actr8) (29, 30) were enriched by LT and/or VbP selection ( Fig. 1A ). We next wanted to verify a few of these unexpected hits. Indeed, we found that RAW 264.7 cells lacking Dnaja2 (Fig. S2A ), a J protein 20 that acts as a co-chaperone of Hsp70s (23, 31), were resistant to both DPP8/9 inhibitor-and LTinduced killing ( Fig. 1B,C) . Treatment of RAW 264.7 cells with sgRNAs targeting Actr5, a gene that encodes a core component of the Ino80 complex, did not result in significant Actr5 protein loss ( Fig. S2B ). However, when cells expressing sgRNAs targeting Actr5 were treated with VbP, nearly complete Actr5 protein loss was observed ( Fig. S2C ). These results are consistent with Actr5 deficiency engendering resistance to VbP (Fig. S2D ). Actr5 -/-RAW 264.7 cells proliferated more slowly than control cells ( Fig. S2E) , accounting for the lack of protein depletion prior to VbP selection. The Ino80 complex genes, including Actr5, were not as enriched in the genome-wide 5 screen by LT as they were by VbP (Fig. 1A) , and Actr5 -/-RAW 264.7 cells were not significantly resistant to LT (Fig. S2F ). Interestingly, we observed loss of other Ino80 subunits in Actr5 -/cells ( Fig. S2C ), indicating that loss of one Ino80 subunit affects the stability or expression of the other subunits. Overall, these results confirm that the VbP and LT resistance screens successfully identified many genes, both expected and unexpected, involved in Nlrp1b-dependent pyroptosis. 10 We were particularly interested in whether any of the newly identified genes could further illuminate the mechanism of Nlrp1b inflammasome activation, and, in particular, the role of the proteasome. On this note, we noticed that several genes involved in the N-end rule proteasomal degradation pathway (32-34), Ubr2, Ubr4, Uba6, Ube2z, and Kcmf1, were highly enriched by LT but not by VbP ( Fig. 1A, Fig. S1C ). The N-end rule pathway recognizes, ubiquitinates, and 15 degrades proteins with destabilizing N-terminal residues (32, 33). Interestingly, Wickliffe and coworkers showed that inhibitors of the N-end rule pathway, bestatin methyl ester and amino acid derivatives (e.g., L-Phe-NH2 and L-Trp-NH2), block LT-mediated cell death (35) . Based on these data, the authors proposed that the LF protease might cleave a key substrate protein to generate a destabilizing N-terminal residue, inducing that protein's degradation via the N-end rule and 20 triggering cell death. However, the key protein substrate of possible N-end rule degradation was not identified, and the direct involvement of N-end rule proteins was not established. Our screening results strongly indicate that the N-end rule pathway is indeed involved in LT-mediated cytotoxicity. We hypothesized that Nlrp1b itself, which was discovered to be directly cleaved by LF after the Wickliffe study (7-9), might be the key LF substrate that is degraded by the N-end rule pathway.
The Nlrp1b protein, like other NLR proteins, contains nucleotide-binding (NACHT) and leucine-rich repeat (LRR) domains ( Fig. 2A ). However, unlike other NLR proteins, Nlrp1b has 5 C-terminal "function-to-find" (FIIND) and caspase activation and recruitment (CARD) domains.
Nlrp1b undergoes post-translational autoproteolysis within the FIIND domain, resulting in N-and C-terminal fragments that remain associated in an auto-inhibited state (36-38). Autoproteolysis is necessary for inflammasome formation (11, 37, 38) , but why autoproteolysis is necessary remains unknown. We first wanted to confirm which domains of Nlrp1b were required for cytotoxicity. 10 We transfected HEK 293T cells stably expressing mouse caspase-1 with constructs encoding various fragments of Nlrp1b ( Fig. 2B ,C). We found that the N-terminal fragment preceding the FIIND autoproteolysis site was completely non-toxic, but all of the C-terminal constructs containing the CARD were toxic. Although the CARD alone did induce some toxicity, maximal toxicity required at least a small portion of the FIIND domain (~50 amino acids), consistent with 15 a previous report (39) . Based on these results, we predicted that N-end rule degradation of the Nlrp1b N-terminus could potentially free the C-terminus to activate caspase-1, as the break in the polypeptide chain in the FIIND domain would prevent the concomitant destruction of the Cterminal CARD domain.
We next asked whether the Nlrp1b protein was degraded after LT cleavage. HEK 293T 20 cells ectopically expressing caspase-1 and Nlrp1b are sensitive to LT-and VbP-induced pyroptosis (11). Consistent with our hypothesis, we saw loss of the full-length Nlrp1b protein after treatment of these cells with LT ( Fig. 2D ). Nlrp1b protein loss was even more pronounced when the cells were pre-treated with cycloheximide to block new protein synthesis. It should be noted that a loss of GST detection in this assay could be simply due to LF proteolytic cleavage and removal of the N-terminal GST-tag. However, the loss of direct Nlrp1b detection (the antibody detects the Cterminus) without the appearance of a slightly lower band is strongly indicative of degradation.
Consistent with our proposed model, we saw less loss of the C-terminal fragment relative to the 5 full-length protein, although some of the C-terminal fragment was also degraded. Similar degradation of the endogenous Nlrp1b protein was observed in RAW 264.7 cells after LT treatment ( Fig. 2E ). Interestingly, VbP also triggered the degradation of Nlrp1b ( Fig. S3 ), indicating that the degradation mechanism of activation is shared between the two stimuli.
We next wanted to determine if LT induces the ubiquitination of Nlrp1b. We transfected 10 Nlrp1b with an N-terminal V5-GFP tag and a C-terminal FLAG tag together with HA-tagged ubiquitin in HEK 293T cells ( Fig. 2F ). After 24 hours, cells were treated with LT and bortezomib (to block degradation of ubiquitinated proteins) for 3 h before lysates were harvested. Some, but not all, Nlrp1b was cleaved by LT at this time point ( Fig. 2F ). Nlrp1b was then immunoprecipitated using anti-FLAG beads and probed with V5, FLAG, and HA antibodies. 15 Consistent with LT-induced ubiquitination of Nlrp1b, we observed greater amounts of HA-tagged and high molecular weight FLAG-tagged species in LT-treated lysates. Notably, we did not see a greater amount of high molecular weight V5-tagged species, which is consistent with the LFuncleaved protein not being ubiquitinated.
We next wanted to confirm that the N-end rule pathway mediated LT-induced degradation 20 of Nlrp1b and was required for LT-induced pyroptosis. Bestatin methyl ester is a cell permeable analog of bestatin, a non-specific inhibitor of aminopeptidases. Aminopeptidases remove Nterminal amino acids from polypeptides, and therefore can reveal destabilizing residues and induce protein degradation via the N-end rule pathway. As such, bestatin methyl ester can inhibit N-end rule-mediated protein degradation (35) . As expected, bestatin methyl ester and bortezomib block LT-induced pyroptosis in RAW 264.7 cells ( Fig. 3A) (35) , and both completely inhibit the degradation of Nlrp1b induced by LT in these cells ( Fig. 3B ). To confirm that N-end rule proteins were involved in LT-induced cell death, we treated RAW 264.7 cells with sgRNAs targeting Ubr2, 5 which encodes an N-end rule E3 ligase (32, 33) that was highly enriched in the LT screen ( ). We reasoned that aminopeptidase inhibition might be increasing the levels of the pyroptosis-inducing DPP8/9 substrate (i.e., aminopeptidases could cleave and inactivate this putative substrate in the absence of DPP8/9 activity), or that the N-end rule pathway also degrades and inactivates the C-terminus of Nlrp1b (i.e., inhibition of the N-end rule could enhance FIIND-CARD toxicity). The former 5 possibility seemed most likely, as bestatin methyl ester enhanced VbP-induced Nlrp1b degradation ( Fig. 3B ). To rule out any involvement of the latter possibility, we expressed the FIIND-CARD fragment of Nlrp1b with an S984M start site ( Fig. 4B ), or fused in frame to ubiquitin to generate the native S984 start site ( Fig. 4C ), and treated with agents that either activate or inhibit this pyroptotic pathway. These agents had no effect on the toxicity of the FIIND-CARD fragment, 10 indicating that all regulation occurs at the level of or upstream of the full-length Nlrp1b protein containing the N-terminus.
Overall, this work has revealed that N-terminal degradation is a common mechanism of Nlrp1b inflammasome activation. Intriguingly, there are at least two distinct mechanisms, one direct ( Fig. 4D ) and one indirect ( Fig. 4E) , that mediate N-terminal degradation. In the direct 15 mechanism identified here, LF protease cleaves Nlrp1b and generates a destabilizing N-terminal residue. As it is unlikely that anthrax LF evolved to intentionally trigger pyroptosis, we speculate that Nlrp1b may serve as a molecular 'booby trap' for LF and possibly other pathogen encoded activities. Consistent with this premise, the Vance laboratory has recently discovered that the S. flexneri E3 ligase IpaH7.8 ubiquitinates and degrades Nlrp1b to activate this inflammasome 20 (Sandstrom et al (2018) biorxiv.org). In the indirect mechanism identified here, we found that the inhibition of DPP8/9 activates an endogenous proteasomal degradation pathway to destroy the Nlrp1b N-terminus. The molecular details of this pathway remain to be determined, and it is not yet clear if this mechanism evolved to sense a specific pathogen or danger signal or if it serves some other purpose. Regardless, here we have identified many genes critical for Nlrp1b-mediated pyroptosis and have demonstrated that N-terminal degradation is a unifying mechanism for Nlrp1b activation. We expect that future studies will leverage these insights to further clarify how Nlrp1b senses specific pathogens and how this inflammasome can be modulated for therapeutic benefit. Competing interests: Authors declare no competing interests.
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Materials and Methods
Cloning. sgRNAs were designed using the Broad Institute's web portal (40) (http://www.broadinstitute.org/rnai/public/analysis-tools/sgrna-design) and cloned into the lentiGuide-puro vector (Addgene #52963) as described previously (41) . The sgRNA sequences 10 are listed in Table S1 . cDNA encoding the full-length mouse Nlrp1b gene was cloned from RAW HEK 293T cells, we first generated cells stably expressing mCasp1. HEK 293T cells were transfected with 2 µg of the pLEX_307 containing mCasp1, 2 µg PAX2 (Addgene, #35002), and incubated for 48 hours. HEK 293T cells were then spinfected with virus-containing supernatant from the transfection for 2 hours at 1000 x g at 30 °C supplemented with 8 µg/mL polybrene. After 2 days, cells were selected for stable expression of mCasp1 using hygromycin (100 µg/mL). HEK 293T cells expressing mCasp1 were then seeded at 0.5 × 10 6 cells/well in 6-well plates in standard growth medium, and 24 h later transiently transfected with indicated constructs encoding Nlrp1b 5 fragments using Fugene HD. After 24 hours, supernatant was then harvested and analyzed for LDH activity, or cells were treated with the indicated agents for 6 additional h before LDH release was assessed.
CellTiter-Glo cell viability assay. DPP8/9 -/and CASP1 -/-THP-1 cells were generated previously Rank algorithm that takes into account the combined sum of the first and second best ranks for sgRNAs for a given gene, as described on the GENE-E website. (allele 1). The LF cleavage and FIIND autoproteolysis sites are indicated. The cartoon is not drawn to scale. (B,C) HEK 293T cells stably expressing mCasp1 were transiently transfected with the indicated constructs (2 µg) for 24 hours, before cell viability was evaluated by LDH release (B) and expression was evaluated by immunoblotting (C). The N-terminal constructs had Nterminal GST tags and the C-terminal constructs had C-terminal Myc-tags. Residues that were 10 mutated to create start sites are indicated. Data are means ± SEM of three biological replicates. ***p < 0.001, **p < 0.01 by two-sided Student's t-test. (D) HEK 293T cells stably expressing mCasp1 were transiently transfected with a construct encoding GST-Nlrp1b (0.03 µg). After 24h, cycloheximide (100 µg/mL) and/or LT (1 µg/mL) was added to the indicated samples, which were then incubated for an additional 6 h. Protein levels were evaluated by immunoblotting. (E) RAW 15 264.7 cells were treated with LT (1 µg/mL, 6 h) before protein levels were evaluated by immunoblotting. (F) Constructs encoding V5-GFP-Nlrp1b-FLAG (shown) and HA-ubiquitin were co-transfected into HEK 293T cells. After 24 hours, cells were treated with bortezomib (1 µg/mL) and BSA (1 µg/mL) or LT (1 µg/mL) for 3 h before lysates were harvested, immunoprecipitated with anti-FLAG beads, and evaluated by immunoblotting. 
